1. Make money.
The main competitors have gone public and made a lot of money. It may only be a matter of time before you are killed. If you continue to compete, you will lose both sides and have no chance of winning. At this time, it is also a good choice to be acquired by the other party.
It is difficult to make money from products and services, but there are many users, which are of strategic value to some companies.
On June 13 last year, Jiuqiang Bio announced that it planned to purchase 95.55% equity of Maixin Bio with Sinopharm Investment * *, with a total transaction price of about 2.628 billion yuan. Among them, Jiuqiang Bio has acquired 65.55% equity of Maixin Bio held by the counterparty, and Sinopharm Investment intends to acquire 30% equity of Maixin Bio held by the counterparty.
Extended data
Beijing Jiuqiang Biotechnology Co., Ltd. is a high-growth enterprise, whose main business is the research and development, production and sales of biochemical diagnostic reagents ("Jinsaier" brand reagents), and has a series of products that are basically synchronized with international development. The company is registered in Zhongguancun, Beijing with a registered capital of 500,828,609 yuan, which is a high-tech enterprise recognized by the state.
In 2006, it was awarded as an independent innovation enterprise in China;
In 2006, it was awarded the title of "China Potential 100" by Forbes.
In 2007
Homocysteine diagnostic kit products have obtained the national torch program project certificate;
Enterprises selected in Forbes' list of "China Potential 100" in 2007;
the year of 2008
Won the "Third Prize of Beijing Science and Technology" issued by Beijing Municipal People's Government;
Obtain the certificate of high-tech enterprise;
For the third year in a row, it was listed on the list of "Forbes China's Most Potential SMEs";
In 2009, cystatin C assay kit, homocysteine assay kit, high-density lipoprotein cholesterol assay kit and low-density lipoprotein cholesterol assay kit won the title of "Beijing Independent Innovation Product";
Won the "membership certificate of Beijing Private Science and Technology Industrialists Association";
Two patents were awarded "utility model patent certificate";
For the fourth consecutive year, it was listed on the list of "Forbes China's Most Potential SMEs";